SHMT2 and cancer: Knocking down SHMT2 significantly blocked the proliferation of LUAD cells, while the proliferation of human bronchial epithelial cells (BEAS‐2B) was not affected, indicating that SHMT2 might be a cancer‐specific target in LUAD (Figure S1G,H, Supporting Information).